COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹825 Cr | ₹86 Cr | ₹72 Cr | ₹92 Cr | ₹74 Cr |
What is the latest Total Non-Current Liabilities ratio of COHANCE LIFESCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹825 Cr |
| Mar2024 | ₹86 Cr |
| Mar2023 | ₹72 Cr |
| Mar2022 | ₹92 Cr |
| Mar2021 | ₹74 Cr |
How is Total Non-Current Liabilities of COHANCE LIFESCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹825 Cr | 859.40 | |
| Mar2024 | ₹86 Cr | 19.83 | |
| Mar2023 | ₹72 Cr | -22.06 | |
| Mar2022 | ₹92 Cr | 24.63 | |
| Mar2021 | ₹74 Cr | - | |
Compare Total Non-Current Liabilities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹17,699.1 Cr | 4% | 9.5% | -47.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | 4% |
9.5% |
-47.9% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses